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Introduction
Medical research is the systematic, rigorous investigation of  
health-related problems in order to generate new knowledge 
or confirm existing knowledge, with the potential benefit of  
evidence-based medical practice and policy guidance.
The validity of  the findings from medical research requires 
a thorough process from design, to data collection and data 
analysis.1 However, the methods that researchers use during 
analyses are often unsuitable for the designs used during 
study conduct. Researchers are supposed to choose the 
study designs at the time of  protocol development, before 
any investigation is carried out. Different study designs 
have different strengths and weaknesses.2 The selected 
design should be the most appropriate design to answer the 
objectives of  a study. This decision is crucial, as study design 
reflects directly on the hypothesis of  interest. Sample size and 
other design aspects of  the study are aimed at achieving valid 
conclusions of  a trial or study.1,3 It is therefore important 
to strive for compatibility between study design and analysis 
plan.
Many authors have reported on common discrepancies in 
medical research, specifically between analysis methods and 
study design.4,5 For instance, after reviewing several published 
studies, Varnell et al. observed that many studies had applied 
inappropriate analysis methods.5 Despite this review, such 
mismatched research reporting remained common about 
7 years later when Suresh and colleagues also established 
that inappropriate analysis methods were commonplace 
in the scientific literature and highlighted the importance 
of  ensuring that studies are adequately powered.6 In their 
findings, common discrepancies included incorrect sample 
size estimation methods, inappropriate analysis methods, 
as well as ignoring clustering in cluster randomised trials 
(CRTs).
Calculating the sample size for a study depends on the 
design of  the study. A study whose sample is too small may 
not be able to answer the research questions posed due to 
lack of  power. In case of  a randomised controlled trial, a 
small unpowered sample would be unethical, as it would be 
subjecting participants to an inferior treatment when the 
results will not be generalisable in the end anyway. On the 
other hand, it would be a waste of  resources to use a sample 
that is too large. In addition, this may be unethical again in 
the context of  a randomised controlled trial. More people 
than needed would be subjected to an inferior treatment or 
to a treatment with many adverse events. As such, proper 
procedures must be carried out in order to come up with an 
appropriate sample size for a study.
Previous work by Mukaka and Moulton emphasised the 
need for consistency between design methods and analysis 
methods, and discussed how contrasting conclusions can 
be arrived at depending on the analysis method of  choice.7 
Choice of  an inappropriate analysis method will put the 
validity of  research results into question. Such findings 
would be misleading and may not be accepted in the scientific 
community.
Chan et al. also described some of  the most common 
discrepancies in medical research.3 They emphasised the 
need to have a well-documented protocol long before the 
commencement of  a trial and further advised researchers to 
avoid deviating from the protocol. The discrepancies that 
were cited are still generally common in contemporary medical 
research. These inconsistencies include failure to state, in a 
publication, whether interim analyses were performed or 
not;  this has a direct impact on the interpretation of  the final 
P-values, taking the probability of  type I error into account. 
Methods of  handling missing data is another problem that 
is commonly inadequately addressed in publications, and 
sometimes no attempt is made to look at the impact of  
missing data. These discrepancies sometimes lead to false 
findings.4 The main reasons for false findings are failure to 
address issues of  bias and how missing data are handled, as 
well as use of  underpowered studies.3,4,8
Understanding the implications of  the discrepancies 
between analysis method and study design, and how such 
discrepancies can potentially be avoided is therefore of  great 
importance for principled research practice. The rationale of  
this short article is to discuss the implications of  analyses 
that are inconsistent with the study design, giving some 
examples and then highlighting potential strategies to avoid 
design–analysis mismatch in research.
Examples of inconsistency between design and 
analysis, and the implications
The shortfall among researchers to match study design 
with appropriate analysis methods is caused by, among 
others things, inadequate training, negligence, and lack of  
coordination between coinvestigators.
When choosing an analysis method, investigators should 
ensure that they understand the main hypothesis that 
has been specified in the protocol. This will allow the 
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the study design when considering the analysis method.
Another common example is where a study is initally 
designed as a superiority trial only to be subsequently 
analysed as a noninferiority trial. Such practice is discouraged 
because the original design may not have enough power to 
answer a noninferiority research question.11 Most likely, 
the choice of  the post hoc noninferiority margin would 
be subjective, which can affect the validity of  the research 
findings. In other cases crossover designs are analysed using 
methods applicable to parallel designs. The interpretation of  
such findings would be misleading because the design and 
the analysis approach do not match. Again, the findings may 
not answer the objectives of  the study. In a related scenario, 
cross-sectional studies are sometimes analysed using risk 
ratios. The interpretation of  the risk ratios in such scenarios 
are questionable, as it is often difficult to establish whether 
the exposure of  interest preceded the outcome of  interest.
Potential solutions
In order to curb the discrepancies between study designs and 
methods of  analysis, a study protocol needs to be developed 
and effort should be made to have it published to enable peer 
review in good time before data analysis. The study protocol 
should clearly describe the study hypotheses, rationale for the 
study, methods for sample size calculation and data analysis, 
anticipated multiple testing, and planned interim analyses. 
Once a study protocol has been developed and approved 
by ethical review committees (and published if  possible), 
a statistical analysis plan (SAP) should be developed. SAPs 
are documents that describe the planned analysis of  a study, 
stating the methods of  data analysis that are consistent with 
the design, as well as the software that will be used for specific 
analyses. It is also encouraged that SAPs contain dummy 
tables for results summaries. Peace et al. previously discussed 
some important aspects of  SAPs.12 Unfortunately, many 
researchers do not develop SAPs. This is likely because of  a 
lack of  awareness of  SAPs or a lack of  knowledge on how 
to prepare one. In some cases, SAPs are prepared without 
reference to the study protocol, either because the protocol 
cannot be traced or because the protocol does not exist 
(especially in the case of  secondary data). SAPs that are not 
based on the study protocol may not be efficient. International 
Conference on Harmonisation (ICH), US Food and Drug 
Administration (FDA), and World Health Organization 
(WHO) guidelines emphasise the use of  SAPs.13 Even in 
cases where investigators understand the importance of  
developing an SAP, the timing is not paid attention to. Many 
researchers who make an effort to develop an SAP often 
develop it as the time to conduct analysis is approaching. In 
such cases, the utility of  the SAP may be compromised. In 
such delayed SAPs, researchers often focus their discussion 
on the assumed correct methods in the analysis plan without 
emphasising the need for the design to match the method 
of  analysis. This frequently leads to mismatched designs 
and analyses. We recommend that all properly designed 
studies have a protocol. We would also recommend that, 
as much as possible, researchers should make a statistical 
analysis plan and that the analysis plan should be developed 
as soon as the final version of  the protocol is completed. 
Methods of  analysis should be consistent with the design 
as reflected in the protocol. We urge researchers to follow 
conventional reporting guidelines, such as the CONSORT 
guidelines and STROBE (STrengthening the Reporting of  
OBservational studies in Epidemiology)14 guidelines, as well 
investigators to reflect on the most appropriate method 
of  analysis to address the research objectives. It is also 
important to check the nature of  data that will be collected, 
that is, whether the data will be collected at 1 time point or 
at several time points from the same subjects. Knowledge of  
the data to be collected informs the researcher of  the most 
relevant approaches to data analysis. For example, suppose 
a researcher designs a randomised controlled trial with the 
aim of  comparing the efficacy of  2 interventions. Study 
participants are randomly allocated into different study 
groups. If  these participants are followed up for a particular 
period of  time and multiple measurements are collected 
from each participant at predefined time points, then this 
leads to some form of  statistical dependence or clustering. If  
all of  the data points are to be used in data analysis, statistical 
methods that take clustering into account will often yield 
substantially different results from the methods that do 
not take the dependence of  observations into account. 
In this case, taking clustering into account is the most 
appropriate approach, which means that publications that 
report the results from independent samples data analyses 
will be providing incorrect findings. Unfortunately, journal 
audiences often do not read the statistical methods and go 
straight to the conclusions section. This leads to incorrect 
messages being disseminated to the general public, leading 
to incorrect new beliefs. We emphasise the importance of  
choosing an appropriate statistical analysis method in order 
to arrive at valid conclusions.
As a second example, suppose a researcher designs a 
randomised controlled trial with the aim of  comparing the 
efficacy of  trial drugs. In this case, subjects are randomly 
allocated to 1 of  the groups in order to receive 1 of  the drugs 
under study. In such studies, participants are usually subject 
to high dropout rates and noncompliance issues, especially 
when the follow-up period is long. In malaria therapeutic 
efficacy studies, the length of  follow-up may be 28 days or 
42 days or 63 days. In other RCTs, the length of  follow-up 
may well be a number of  years. During the analyses of  such 
data, a researcher might decide to exclude all participants 
with noncompliance and dropout issues, thereby reducing 
the original sample size and hence affecting the statistical 
power. Although it is still common practice for researchers 
to perform complete-case analysis (removing records 
with missing observations), the findings may no longer 
be representative of  the population from which the study 
sample came from. In fact, such practice, though common, 
is against the Consolidated Standards of  Reporting Trials 
(CONSORT) guidelines.8 Findings from such studies may 
not answer the intended research questions. This kind of  
sloppiness in analysis can be easily avoided by strategising the 
analysis approach during protocol development. In line with 
this study design, it is recommended that the main strategy 
for analysis of  RCTs is to use an intention to treat (ITT) 
approach, which emphasises that all randomised subjects 
should be included in the analysis, irrespective of  whatever 
happens to them after randomisation.9 The advantage of  
ITT is that not only will the statistical power of  the study 
be maintained, but the principle of  randomisation will also 
remain intact and consequently the treatment groups would 
be comparable with respect to baseline characteristics.10 On 
the other hand, if  the study was observational, ITT may 
not have a place and interpretation of  the findings is not 
necessarily the same as those of  a randomised trial. This 
again demonstrates the importance of  paying attention to 
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as other relevant reporting guidelines. If  analyses will be 
done by someone who did not take part in the design of  the 
study, the study protocol and the SAP should accompany 
the data. We advise that even if  researchers know how to 
perform statistical analyses on their own, it is still good 
practice to consult a statistician to verify that analyses have 
been done correctly. We also recommend that a statistician 
be consulted to look at the statistical aspects of  a manuscript 
before submission to a journal. In that way, any discrepancy 
between the study design and method of  analysis may be 
avoided, and additional improvements can be made. Of  
course, consulting a statistician is easier said than done if  
researchers are not acquainted with medical statisticians who 
are willing and able to provide such expertise. On that note, 
we would highly encourage researchers to regularly include 
budget lines for (medical) statistical support in their grant 
applications. It should be noted that many statisticians are 
more than satisfied with the non-financial reward of  being 
included in the author lists of  work for which they contribute 
statistical guidance; this may be even more welcome than 
remuneration, as it allows statisticians to work on trials in 
their regular work time on the grounds that the work will 
contribute to their academic curriculum vitae and hence 
their career development.
We also note that peer reviewing of  SAPs is often not 
considered. In this regard, we would encourage that SAPs be 
peer reviewed. This may be achieved by sending an SAP to 
statistician colleagues or by including an SAP with a protocol 
when submitting a protocol for peer review and publication. 
Among other journals, Trials publishes protocols and may be 
a useful channel for having your SAP reviewed alongside a 
protocol.
Conclusions
We emphasise that methods of  analysis should correspond 
with study design. There is need for a well-planned and an 
early-timed statistical analysis plan, which can help address 
the issue of  discrepancy between study design and the 
analysis method. We also encourage that researchers include 
a statistician as a collaborator or a coinvestigator in research 
studies. In that way, they become part and parcel of  the 
study from the design stage, to data analysis and manuscript 
development.
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